Quick Answer
MBX Biosciences, Inc. reported Research And Development Expense of $79.16 million for the year ending 2025.
- MBX Biosciences, Inc. showed an increase of +37.9% in Research And Development Expense from 2024 to 2025.
- This data is from MBX Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 3 years of available data (2023 to 2025), MBX Biosciences, Inc.'s Research And Development Expense has grown by 177.4%.
- Historical annual values: Fiscal year 2025: $79.16 million | Fiscal year 2024: $57.42 million | Fiscal year 2023: $28.53 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: